Tau PET imaging constitutes a new and rapidly evolving field with numerous methodological challenges. The goal of the Progress in Tau Imaging meeting is to engage investigators employing Tau-PET radioligands with the PET experts at the Society for Cerebral Blood Flow & Metabolism. Topics will include an overview of available radioligands, issues related to off-target binding, autoradiography, and the best practices for reporting Tau-PET data. It is expected that the Progress in Tau Imaging satellite meeting will continue as a yearly event, taking place alongside the International Society for Cerebral Blood Flow & Metabolism conference on odd years, and alongside the Neuroreceptor Mapping conference in even years.
Prof. Julie Price
Harvard Medical SchoolDesired properties of TAU PET ligands.
Prof. Victor Villemagne
The University of Melbourne, AustraliaImaging with [18F] PI-2620
Dr. Tharick Pascoal
McGill University, CanadaImaging with [18F] MK-6240
Dr. Antoine Leuzy
Lund University, SwedenImaging with [18F] RO-948
Dr. Makoto Higuchi
National Institute of Radiological Sciences, JapanImaging with [11C] PBB3 Series